Ms. Inamdar joined Zymeworks in September 2023 and currently serves as Vice President, Investor Relations. She brings more than a decade of experience in investor relations, corporate communications, and strategic stakeholder engagement across the biotechnology and life sciences industries. In her current role, Ms. Inamdar leads the Company’s global investor relations strategy, oversees all investor-facing communications, and advises the Chief Executive Officer and Board of Directors on market positioning and key valuation drivers.

Prior to joining Zymeworks, Ms. Inamdar held senior roles at Liminal BioSciences, including Associate Director of Investor Relations and Communications, where she was responsible for investor engagement, financial communications, and ESG initiatives. Her professional background also includes advisory work with early-stage biotechnology companies, providing strategic counsel on investor relations, business development, and commercial strategy for organizations pursuing seed and venture capital financing. Earlier in her career, she held positions at Prometic BioSciences and Astrea BioSeparations, with a focus on digital strategy, marketing, and business development.

Ms. Inamdar holds post-graduate degrees in Public Relations, and Digital Marketing from the Chartered Institute of Public Relations, and The Institute of Direct and Digital Marketing respectively. She earned a BSc (Honours) in Psychology from the University of Westminster.